VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 117 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,281,000 | -0.5% | 512,051 | +10.8% | 0.93% | +47.3% |
| Q4 2015 | $4,302,000 | -25.7% | 462,051 | -10.0% | 0.63% | -14.7% |
| Q3 2015 | $5,791,000 | -11.1% | 513,390 | 0.0% | 0.74% | +15.8% |
| Q2 2015 | $6,515,000 | +28.9% | 513,390 | -5.5% | 0.64% | +21.3% |
| Q1 2015 | $5,054,000 | -4.2% | 543,390 | +47.5% | 0.53% | -41.5% |
| Q4 2014 | $5,275,000 | +132.7% | 368,390 | +68.7% | 0.90% | +221.1% |
| Q3 2014 | $2,267,000 | +0.1% | 218,390 | +56.0% | 0.28% | -49.8% |
| Q2 2014 | $2,265,000 | +114.5% | 140,000 | +115.4% | 0.56% | +131.5% |
| Q1 2014 | $1,056,000 | -10.4% | 65,000 | -31.6% | 0.24% | -26.5% |
| Q4 2013 | $1,179,000 | – | 95,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
| Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
| Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
| ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
| Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
| Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
| PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |